LISINOPRIL/HYDROCHLOROTHIAZIDE TEVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) thermoformée(s) aluminium PVC PVDC de 28 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400936681644
  • CIP7 3668164
  • CIS 62159778

What the source publishes

Holder
TEVA SANTE
Active ingredients
HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDRE, LISINOPRIL DIHYDRATÉ
Form
comprimé sécable
Package
plaquette(s) thermoformée(s) aluminium PVC PVDC de 28 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2005-03-08
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400936681644
{
  "cis": "62159778",
  "cip7": "3668164",
  "form": "comprimé sécable",
  "name": "LISINOPRIL/HYDROCHLOROTHIAZIDE TEVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) thermoformée(s) aluminium PVC PVDC de 28 comprimé(s)",
  "cip13": "3400936681644",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "4.54",
  "authorisedOn": "2005-03-08",
  "compositions": [
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "nature": "SA",
      "strength": "12,5 mg",
      "linkageNumber": "3",
      "substanceCode": "02064",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "LISINOPRIL ANHYDRE",
      "nature": "FT",
      "strength": "20 mg",
      "linkageNumber": "8",
      "substanceCode": "15304",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "LISINOPRIL DIHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "8",
      "substanceCode": "60255",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.52",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LISINOPRIL/HYDROCHLOROTHIAZIDE TEVA 20 mg/12,5 mg, comprimé sécable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) aluminium PVC PVDC de 28 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2006-04-24",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "HYDROCHLOROTHIAZIDE",
    "LISINOPRIL ANHYDRE",
    "LISINOPRIL DIHYDRATÉ"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400936681644"